What is the recommended treatment for a male patient of reproductive age with chronic prostatitis and pus cells in semen analysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Pus Cells in Semen Analysis

For a male patient of reproductive age with pus cells (leukocytospermia) in semen analysis and chronic prostatitis, antibiotic therapy is only recommended if chronic bacterial prostatitis (Type II) is confirmed through proper microbiological testing, not based on leukocytospermia alone. 1

Critical Diagnostic Distinction

The presence of pus cells (white blood cells) in semen does not automatically warrant antibiotic treatment. The 2025 European Association of Urology guidelines explicitly state that leukocytospermia without evidence of infective organisms does not improve conception rates with treatment alone 1. This represents a significant shift from older practices of empirically treating all cases of pyospermia.

Required Diagnostic Workup Before Treatment

Before initiating antibiotics, you must establish whether this is true bacterial prostatitis:

  • Perform the Meares-Stamey four-glass test (or simplified two-glass test in routine practice) to differentiate chronic bacterial prostatitis from chronic pelvic pain syndrome 2, 3
  • Obtain urine culture and prostatic secretion cultures to identify specific pathogens 1, 4
  • Test for sexually transmitted infections including Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Ureaplasma urealyticum using nucleic acid amplification tests (NAAT) on first-void urine or urethral swabs 1
  • Evaluate the sexual partner for sexually transmitted infections, as these may be the underlying cause 1, 3

When Antibiotics ARE Indicated

Confirmed Chronic Bacterial Prostatitis (Type II)

If microbiological testing confirms bacterial infection, fluoroquinolones are first-line therapy 1, 4:

  • Levofloxacin 500 mg orally once daily for minimum 4 weeks 5, 4, 2
  • Alternative: Ciprofloxacin 500 mg orally twice daily for minimum 4 weeks 4, 2, 6

The 2025 EAU guidelines note that fluoroquinolones cure approximately 70% of chronic bacterial prostatitis cases when given for 2-4 weeks 1, 6. Levofloxacin is preferred over ciprofloxacin due to better prostatic penetration and once-daily dosing 2.

Sexually Transmitted Infections

If STI pathogens are identified:

  • For Chlamydia trachomatis: Doxycycline 100 mg orally twice daily for 7 days 1, 7
  • For Ureaplasma urealyticum: Doxycycline 100 mg orally twice daily for 7 days 1
  • For Mycoplasma genitalium: Azithromycin 500 mg on day 1, then 250 mg daily for 4 days (or moxifloxacin 400 mg daily for 7-14 days if macrolide-resistant) 1

The 2025 EAU guidelines specifically note that Ureaplasma urealyticum and Mycoplasma hominis are associated with male infertility, but Ureaplasma parvum and Mycoplasma genitalium strains are not 1.

When Antibiotics Are NOT Indicated

Leukocytospermia Without Confirmed Infection

Do not treat leukocytospermia alone without documented bacterial infection 1. A 2025 meta-analysis demonstrated that leukocytospermia in subfertile men was not associated with lower fertility at assisted reproductive technology or altered semen quality in men without symptoms of genital tract infections 1.

Chronic Pelvic Pain Syndrome (Type III)

If testing excludes bacterial infection, this is chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). There is no evidence that antibiotics increase the probability of natural conception in CP/CPPS 1. The 2025 EAU guidelines emphasize that randomized controlled trials with pregnancy and live birth rates as primary outcomes are needed to evaluate antibiotics in this setting 1.

Alternative Management for Non-Bacterial Cases

When bacterial infection is excluded:

  • Alpha-blockers (tamsulosin, alfuzosin) for urinary symptoms show the strongest evidence with NIH-CPSI score improvements of -10.8 to -4.8 compared to placebo 4
  • NSAIDs (ibuprofen) for pain with modest NIH-CPSI improvements of -2.5 to -1.7 4
  • Lifestyle modifications including weight loss, physical exercise, and smoking cessation can enhance sperm parameters 1
  • Antioxidant therapy may improve live birth rates, though evidence quality is low 1
  • Probiotic/prebiotic supplementation showed improvements in sperm parameters and DNA integrity in one RCT 1

Critical Pitfalls to Avoid

  • Never prescribe antibiotics based solely on semen leukocyte count without microbiological confirmation of infection 1
  • Do not continue antibiotics beyond 2-4 weeks without reassessing effectiveness 8
  • Always treat sexual partners when sexually transmitted pathogens are identified to prevent reinfection 1
  • Recognize that up to 90% of "chronic prostatitis" cases are actually CP/CPPS without bacterial infection and will not benefit from antibiotics 1, 3
  • Consider antibiotic resistance patterns - obtain cultures before treatment when possible, especially for gonorrhea 1

Follow-Up Protocol

  • Reevaluate at 3 days if symptoms worsen or fail to improve 1
  • Repeat semen analysis and cultures 5-18 days after completing antibiotic therapy if bacterial prostatitis was treated 5
  • Screen for cardiovascular risk factors as infertile men have higher cardiovascular and overall mortality 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Multidisciplinary approach to prostatitis.

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2019

Research

Prostatitis: A Review.

JAMA, 2025

Guideline

Doxycycline for Bladder Pain in Men

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.